Influence of Several Compounds and Drugs on the Renal Uptake of Radiolabeled Affibody Molecules

por Garousi, Javad, Vorobyeva, Anzhelika, Altai, Mohamed
Publicado 2020

Imaging using radiolabelled targeted proteins: radioimmunodetection and beyond

por Garousi, Javad, Orlova, Anna, Frejd, Fredrik Y., Tolmachev, Vladimir
Publicado 2020

On the prevention of kidney uptake of radiolabeled DARPins

por Altai, Mohamed, Garousi, Javad, Rinne, Sara S., Schulga, Alexey, Deyev, Sergey, Vorobyeva, Anzhelika
Publicado 2020

Preclinical Evaluation of [(68)Ga]Ga-DFO-ZEGFR:2377: A Promising Affibody-Based Probe for Noninvasive PET Imaging of EGFR Expression in Tumors

por Oroujeni, Maryam, Garousi, Javad, Andersson, Ken G., Löfblom, John, Mitran, Bogdan, Orlova, Anna, Tolmachev, Vladimir
Publicado 2018

Comparative evaluation of tumor targeting using the anti-HER2 ADAPT scaffold protein labeled at the C-terminus with indium-111 or technetium-99m

por Garousi, Javad, Lindbo, Sarah, Mitran, Bogdan, Buijs, Jos, Vorobyeva, Anzhelika, Orlova, Anna, Tolmachev, Vladimir, Hober, Sophia
Publicado 2017

Investigation of a Pharmacological Approach for Reduction of Renal Uptake of Radiolabeled ADAPT Scaffold Protein

por Vorobyeva, Anzhelika, Oroujeni, Maryam, Lindbo, Sarah, Hober, Sophia, Xu, Tianqi, Liu, Yongsheng, Rinne, Sara S., Garousi, Javad
Publicado 2020

Feasibility of imaging of epidermal growth factor receptor expression with ZEGFR:2377 affibody molecule labeled with (99m)Tc using a peptide-based cysteine-containing chelator

por Andersson, Ken G., Oroujeni, Maryam, Garousi, Javad, Mitran, Bogdan, Ståhl, Stefan, Orlova, Anna, Löfblom, John, Tolmachev, Vladimir
Publicado 2016

Imaging of CAIX-expressing xenografts in vivo using (99m)Tc-HEHEHE-ZCAIX:1 Affibody molecule

por HONARVAR, HADIS, GAROUSI, JAVAD, GUNNERIUSSON, ELIN, HÖIDÉN-GUTHENBERG, INGMARIE, ALTAI, MOHAMED, WIDSTRÖM, CHARLES, TOLMACHEV, VLADIMIR, FREJD, FREDRIK Y.
Publicado 2014

PET imaging of epidermal growth factor receptor expression in tumours using (89)Zr-labelled ZEGFR:2377 affibody molecules

por GAROUSI, JAVAD, ANDERSSON, KEN G., MITRAN, BOGDAN, PICHL, MARIE-LOUISE, STÅHL, STEFAN, ORLOVA, ANNA, LÖFBLOM, JOHN, TOLMACHEV, VLADIMIR
Publicado 2016

Experimental HER2-Targeted Therapy Using ADAPT6-ABD-mcDM1 in Mice Bearing SKOV3 Ovarian Cancer Xenografts: Efficacy and Selection of Companion Imaging Counterpart

por Garousi, Javad, Xu, Tianqi, Liu, Yongsheng, Vorontsova, Olga, Hober, Sophia, Orlova, Anna, Tolmachev, Vladimir, Gräslund, Torbjörn, Vorobyeva, Anzhelika
Publicado 2022

Feasibility of Imaging EpCAM Expression in Ovarian Cancer Using Radiolabeled DARPin Ec1

por Vorobyeva, Anzhelika, Konovalova, Elena, Xu, Tianqi, Schulga, Alexey, Altai, Mohamed, Garousi, Javad, Rinne, Sara S., Orlova, Anna, Tolmachev, Vladimir, Deyev, Sergey
Publicado 2020

Radionuclide Molecular Imaging of EpCAM Expression in Triple-Negative Breast Cancer Using the Scaffold Protein DARPin Ec1

por Vorobyeva, Anzhelika, Bezverkhniaia, Ekaterina, Konovalova, Elena, Schulga, Alexey, Garousi, Javad, Vorontsova, Olga, Abouzayed, Ayman, Orlova, Anna, Deyev, Sergey, Tolmachev, Vladimir
Publicado 2020

Cyclic versus Noncyclic Chelating Scaffold for (89)Zr-Labeled ZEGFR:2377 Affibody Bioconjugates Targeting Epidermal Growth Factor Receptor Overexpression

por Summer, Dominik, Garousi, Javad, Oroujeni, Maryam, Mitran, Bogdan, Andersson, Ken G., Vorobyeva, Anzhelika, Löfblom, John, Orlova, Anna, Tolmachev, Vladimir, Decristoforo, Clemens
Publicado 2017

Influence of composition of cysteine-containing peptide-based chelators on biodistribution of (99m)Tc-labeled anti-EGFR affibody molecules

por Oroujeni, Maryam, Andersson, Ken G., Steinhardt, Xenia, Altai, Mohamed, Orlova, Anna, Mitran, Bogdan, Vorobyeva, Anzhelika, Garousi, Javad, Tolmachev, Vladimir, Löfblom, John
Publicado 2018

The Use of a Non-Conventional Long-Lived Gallium Radioisotope (66)Ga Improves Imaging Contrast of EGFR Expression in Malignant Tumours Using DFO-ZEGFR:2377 Affibody Molecule

por Oroujeni, Maryam, Xu, Tianqi, Gagnon, Katherine, Rinne, Sara S., Weis, Jan, Garousi, Javad, Andersson, Ken G., Löfblom, John, Orlova, Anna, Tolmachev, Vladimir
Publicado 2021

Targeting HER2 Expressing Tumors with a Potent Drug Conjugate Based on an Albumin Binding Domain-Derived Affinity Protein

por Garousi, Javad, Ding, Haozhong, von Witting, Emma, Xu, Tianqi, Vorobyeva, Anzhelika, Oroujeni, Maryam, Orlova, Anna, Hober, Sophia, Gräslund, Torbjörn, Tolmachev, Vladimir
Publicado 2021

HER2-Specific Pseudomonas Exotoxin A PE25 Based Fusions: Influence of Targeting Domain on Target Binding, Toxicity, and In Vivo Biodistribution

por Ding, Haozhong, Altai, Mohamed, Yin, Wen, Lindbo, Sarah, Liu, Hao, Garousi, Javad, Xu, Tianqi, Orlova, Anna, Tolmachev, Vladimir, Hober, Sophia, Gräslund, Torbjörn
Publicado 2020

Comparison of tumor-targeting properties of directly and indirectly radioiodinated designed ankyrin repeat protein (DARPin) G3 variants for molecular imaging of HER2

por Vorobyeva, Anzhelika, Sсhulga, Alexey, Konovalova, Elena, Güler, Rezan, Mitran, Bogdan, Garousi, Javad, Rinne, Sara, Löfblom, John, Orlova, Anna, Deyev, Sergey, Tolmachev, Vladimir
Publicado 2019

The use of radiocobalt as a label improves imaging of EGFR using DOTA-conjugated Affibody molecule

por Garousi, Javad, Andersson, Ken G., Dam, Johan H., Olsen, Birgitte B., Mitran, Bogdan, Orlova, Anna, Buijs, Jos, Ståhl, Stefan, Löfblom, John, Thisgaard, Helge, Tolmachev, Vladimir
Publicado 2017

Optimal composition and position of histidine-containing tags improves biodistribution of (99m)Tc-labeled DARPin G3

por Vorobyeva, Anzhelika, Schulga, Alexey, Konovalova, Elena, Güler, Rezan, Löfblom, John, Sandström, Mattias, Garousi, Javad, Chernov, Vladimir, Bragina, Olga, Orlova, Anna, Tolmachev, Vladimir, Deyev, Sergey M.
Publicado 2019